Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 5/20 | 0.73 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.73 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20942840 | 1.00 | SLC6A2 (0.73) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7812301 | 0.87 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7086307 | 0.86 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7086304 | 0.86 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL3467519 | 0.86 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL6923261 | 0.84 | SLC6A2 (1.00) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL6923257 | 0.84 | SLC6A2 (1.00) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL6829748 | 0.82 | SLC6A2 (0.76) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL8602659 | 0.82 | SLC6A2 (0.76) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL6829747 | 0.82 | SLC6A2 (0.76) | SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2568805-B1 | A MEDICAL FLUID, A METHOD OF TREATMENT AND USE OF THE FLUID | XVIVO PERFUSION AB (SE) | 2019-05-01 | — | — | EP | claimed |
| US-20160354359-A1 | COMPOSITION COMPRISING NOR-ADRENALINE AND A NET INHIBITOR FOR ADMINISTERING TO A BRAIN-DEAD, HEART-BEATING POTENTIAL ORGAN DONOR | XVIVO PERFUSION AB (SE) | 2016-12-08 | — | — | US | claimed |
| EP-2568805-B1 | A MEDICAL FLUID, A METHOD OF TREATMENT AND USE OF THE FLUID | XVIVO PERFUSION AB (SE) | 2019-05-01 | — | — | EP | disclosed |
| US-10271540-B2 | Medical fluid, a method of treatment and use of the fluid | XVIVO PERFUSION AB (SE) | 2019-04-30 | — | — | US | disclosed |
| US-20160354359-A1 | COMPOSITION COMPRISING NOR-ADRENALINE AND A NET INHIBITOR FOR ADMINISTERING TO A BRAIN-DEAD, HEART-BEATING POTENTIAL ORGAN DONOR | XVIVO PERFUSION AB (SE) | 2016-12-08 | — | — | US | disclosed |
| US-20160338343-A1 | MEDICAL FLUID, A METHOD OF TREATMENT AND USE OF THE FLUID | XVIVO PERFUSION AB (SE) | 2016-11-24 | — | — | US | disclosed |